- COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES
-
This invention relates to CXCR4 inhibitors and their use in treating and/or preventing a variety of angiogenic, microvascular and ocular disorders including primary indications for diabetic retinopathy, macular degeneration (such as wet or neovascular age
- -
-
Page/Page column 30-31
(2008/06/13)
-
- Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists
-
PCT No. PCT/GB95/02759 Sec. 371 Date Jul. 28, 1997 Sec. 102(e) Date Jul. 28, 1997 PCT Filed Nov. 27, 1995 PCT Pub. No. WO96/17842 PCT Pub. Date Jun. 13, 1996A class of substituted azetidine, pyrrolidine and piperidine derivatives are selective agonists of 5-HT1-like receptors, being potent agonists of the human 5-HT1D alpha receptor subtype whilst possessing at least a 10-fold selective affinity for the 5-HT1D alpha receptor subtype relative to the 5-HT1D beta subtype; they are therefore useful in the treatment and/or prevention of clinical conditions, in particular migraine and associated disorders, for which a subtype-selective agonist of 5-HT1D receptors is indicated, whilst eliciting fewer side-effects, notably adverse cardiovascular events, than those associated with non-subtype-selective 5-HT1D receptor agonists.
- -
-
-